| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 653 | 2022 |
| Macrophage polarity in cancer: a review M Najafi, N Hashemi Goradel, B Farhood, E Salehi, MS Nashtaei, ... Journal of cellular biochemistry 120 (3), 2756-2765, 2019 | 443 | 2019 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 435 | 2022 |
| Cancer stem cell (CSC) resistance drivers M Najafi, K Mortezaee, J Majidpoor Life sciences 234, 116781, 2019 | 334 | 2019 |
| Steps in metastasis: an updated review J Majidpoor, K Mortezaee Medical Oncology 38 (1), 3, 2021 | 198 | 2021 |
| The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives J Majidpoor, K Mortezaee Clinical Immunology 226, 108707, 2021 | 155 | 2021 |
| Angiogenesis as a hallmark of solid tumors-clinical perspectives J Majidpoor, K Mortezaee Cellular Oncology 44, 715-737, 2021 | 145 | 2021 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 110 | 2022 |
| Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance M Najafi, B Farhood, K Mortezaee, E Kharazinejad, J Majidpoor, R Ahadi Journal of cancer research and clinical oncology 146, 19-31, 2020 | 110 | 2020 |
| The current knowledge concerning solid cancer and therapy M Najafi, J Majidpoor, H Toolee, K Mortezaee Journal of biochemical and molecular toxicology 35 (11), e22900, 2021 | 85 | 2021 |
| Regulatory role of microRNAs on PTEN signaling S Ghafouri-Fard, A Abak, H Shoorei, M Mohaqiq, J Majidpoor, A Sayad, ... Biomedicine & Pharmacotherapy 133, 110986, 2021 | 65 | 2021 |
| Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4 K Mortezaee, N Khanlarkhani, F Sabbaghziarani, S Nekoonam, ... Cell and tissue research 369, 303-312, 2017 | 65 | 2017 |
| Stromal reprogramming: a target for tumor therapy M Najafi, K Mortezaee, J Majidpoor Life sciences 239, 117049, 2019 | 61 | 2019 |
| Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications J Majidpoor, K Mortezaee Biomedicine & Pharmacotherapy 145, 112419, 2022 | 55 | 2022 |
| The impact of hypoxia on immune state in cancer K Mortezaee, J Majidpoor Life sciences 286, 120057, 2021 | 55 | 2021 |
| The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process S Ghafouri-Fard, A Abak, FT Anamag, H Shoorei, J Majidpoor, M Taheri Biomedicine & Pharmacotherapy 137, 111279, 2021 | 50 | 2021 |
| An update on the role of miR-124 in the pathogenesis of human disorders S Ghafouri-Fard, H Shoorei, Z Bahroudi, A Abak, J Majidpoor, M Taheri Biomedicine & Pharmacotherapy 135, 111198, 2021 | 50 | 2021 |
| Exploring the role of non-coding RNAs in autophagy S Ghafouri-Fard, H Shoorei, M Mohaqiq, J Majidpoor, MA Moosavi, ... Autophagy 18 (5), 949-970, 2022 | 48 | 2022 |
| Interleukin-2 therapy of cancer-clinical perspectives J Majidpoor, K Mortezaee International immunopharmacology 98, 107836, 2021 | 47 | 2021 |
| Non-coding RNAs modulate function of extracellular matrix proteins NA Dilmaghnai, H Shoorei, G Sharifi, M Mohaqiq, J Majidpoor, ME Dinger, ... Biomedicine & Pharmacotherapy 136, 111240, 2021 | 47 | 2021 |
Keywan MortezaeeAssociate Professor of Anatomy, Kurdistan University of Medical SciencesVerified email at muk.ac.ir
